Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sialic acid-conjugate modified doxorubicin nanoplatform for treating neutrophil-related inflammation
Shuo Wang, Xiaoxue Lai, Cong Li, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 612-627
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 151
Neutrophil-based Trojan horse containing polymer nano-therapeutics for sono-activatable ferroptosis-immunotherapy of orthotopic glioma
Mengbin Ding, Anni Zhu, Yijing Zhang, et al.
Nano Today (2024) Vol. 57, pp. 102398-102398
Closed Access | Times Cited: 9
Neutrophil‐Targeting Semiconducting Polymer Nanotheranostics for NIR‐II Fluorescence Imaging‐Guided Photothermal‐NO‐Immunotherapy of Orthotopic Glioblastoma
Jiansheng Liu, Danling Cheng, Anni Zhu, et al.
Advanced Science (2024) Vol. 11, Iss. 39
Open Access | Times Cited: 9
Disrupting the dangerous alliance: Dual anti-inflammatory and anticoagulant strategy targets platelet-neutrophil crosstalk in sepsis
Sa Chen, Aijia Wu, Xinran Shen, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 814-831
Closed Access | Times Cited: 1
Nanotechnology reinforced neutrophil-based therapeutic strategies for inflammatory diseases therapy
Jiahe Wu, Teng Ma, Manning Zhu, et al.
Nano Today (2022) Vol. 46, pp. 101577-101577
Closed Access | Times Cited: 29
Minimalist Nanocomplex with Dual Regulation of Endothelial Function and Inflammation for Targeted Therapy of Inflammatory Vascular Diseases
Shuo Wang, Yuequan Wang, Xiaoxue Lai, et al.
ACS Nano (2023) Vol. 17, Iss. 3, pp. 2761-2781
Closed Access | Times Cited: 22
Hierarchical superparamagnetic metal–organic framework nanovectors as anti-inflammatory nanomedicines
Heng Zhao, Saad Sene, Angelika Mielcarek, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 14, pp. 3195-3211
Open Access | Times Cited: 18
Immunomodulatory hydrogels for skin wound healing: cellular targets and design strategy
Yinhai He, Ying Cen, Meng Tian
Journal of Materials Chemistry B (2023) Vol. 12, Iss. 10, pp. 2435-2458
Closed Access | Times Cited: 18
Stimuli-responsive and biomimetic delivery systems for sepsis and related complications
Eman Abdel Rahman Ismail, Nikita Devnarain, Thirumala Govender, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 1048-1070
Closed Access | Times Cited: 23
Overcoming neutrophil-induced immunosuppression in postoperative cancer therapy: Combined sialic acid-modified liposomes with scaffold-based vaccines
Cong Li, Lihong Wang, Kexin Zhang, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 2, pp. 100906-100906
Open Access | Times Cited: 4
Nanotechnology‐Mediated Immunomodulation Strategy for Inflammation Resolution
Ying Li, Wen Liu, Yuanchao Wang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 27
Closed Access | Times Cited: 4
Innate immunity-modulating nanobiomaterials for controlling inflammation resolution
Yongjiang Li, Wei Chen, Seyoung Koo, et al.
Matter (2024) Vol. 7, Iss. 11, pp. 3811-3844
Closed Access | Times Cited: 4
Therapeutic applications of nanoparticles targeting neutrophil and extracellular traps
Nastaran Rezaei, Matthias Zadory, Samuel Babity, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 636-653
Closed Access | Times Cited: 11
Metal‐Organic Frameworks for the Therapy of Inflammatory Diseases
Heng Zhao, Christian Serre, Nathalie Steunou
Advanced Healthcare Materials (2025)
Closed Access
Advances in nanodelivery systems based on apoptosis strategies for enhanced rheumatoid arthritis therapy
Zongquan Zhang, Yilin Liu, Xiaoya Liang, et al.
Acta Biomaterialia (2025)
Closed Access
Sialic acid-mediated photochemotherapy enhances infiltration of CD8+ T cells from tumor-draining lymph nodes into tumors of immunosenescent mice
Dezhi Sui, Changzhi Li, Xueying Tang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 1, pp. 425-439
Open Access | Times Cited: 11
Transformable binary-prodrug nanoparticles harness heterogeneity of neutrophils to overcome multidrug resistance and promote pyroptosis in cancer
Dezhi Sui, Kaituo Zhang, Zhaowei Qi, et al.
Applied Materials Today (2024) Vol. 37, pp. 102110-102110
Closed Access | Times Cited: 2
Inflammation-targeted sialic acid-dexamethasone conjugates for reducing the side effects of glucocorticoids
Hongbing Liu, Dongdong Liu, Muse Ji, et al.
International Journal of Pharmaceutics (2022) Vol. 622, pp. 121900-121900
Closed Access | Times Cited: 8
Endothelial cell protein C receptor regulates neutrophil extracellular trap–mediated rheumatoid arthritis disease progression
Xuanqi Liu, Yinping Huo, Jingyang Zhao, et al.
International Immunopharmacology (2022) Vol. 112, pp. 109249-109249
Closed Access | Times Cited: 7
Sialic Acid Conjugate-Modified Cationic Liposomal Paclitaxel for Targeted Therapy of Lung Metastasis in Breast Cancer: What a Difference the Cation Content Makes
Wenliang Sun, Chao Han, Ruirui Ge, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1625-1638
Closed Access | Times Cited: 1
Intravenous injection of nattokinase-heparin electrostatic complex improves the therapeutic effect of advanced tumors by dissolving cancer-related thrombosis
Dazhi Wang, Yanmei Kou, Tiantian Guo, et al.
Life Sciences (2024) Vol. 355, pp. 122935-122935
Closed Access | Times Cited: 1
Sialic acid-modified doxorubicin liposomes target tumor-related immune cells to relieve multiple inhibitions of CD8 + T cells
Zhouchunxiao Du, Dezhi Sui, Dongzhe Xin, et al.
Journal of Liposome Research (2024) Vol. 34, Iss. 3, pp. 464-474
Closed Access | Times Cited: 1
Optimization design of sialic acid derivatives enhances the performance of liposomes for modulating immunosuppressive tumor microenvironments
Dezhi Sui, Kaifan Liang, Yangxu Gui, et al.
Life Sciences (2022) Vol. 310, pp. 121081-121081
Closed Access | Times Cited: 6
Inflammation-responsive drug delivery nanosystems for treatment of bacterial-induced sepsis
Vincent O. Nyandoro, Calvin A. Omolo, Eman Abdel Rahman Ismail, et al.
International Journal of Pharmaceutics (2023) Vol. 644, pp. 123346-123346
Closed Access | Times Cited: 3
Nanotechnology for Enhanced Cytoplasmic and Organelle Delivery of Bioactive Molecules to Immune Cells
Xiaoyu Li, U.T. Omonova, Amari Mohamed Khamis, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 6, pp. 1065-1083
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top